张海琴, 李顺平, 冯俊超. 商业健康保险在中国罕见病医疗保障中的应用现状、问题及对策[J]. 罕见病研究, 2022, 1(1): 84-88. DOI: 10.12376/j.issn.2097-0501.2022.01.014
引用本文: 张海琴, 李顺平, 冯俊超. 商业健康保险在中国罕见病医疗保障中的应用现状、问题及对策[J]. 罕见病研究, 2022, 1(1): 84-88. DOI: 10.12376/j.issn.2097-0501.2022.01.014
ZHANG Haiqin, LI Shunping, FENG Junchao. Application Status, Problems and Suggestions of Commerical Health Insurance in Medical Security for Rare Dsieases in China[J]. Journal of Rare Diseases, 2022, 1(1): 84-88. DOI: 10.12376/j.issn.2097-0501.2022.01.014
Citation: ZHANG Haiqin, LI Shunping, FENG Junchao. Application Status, Problems and Suggestions of Commerical Health Insurance in Medical Security for Rare Dsieases in China[J]. Journal of Rare Diseases, 2022, 1(1): 84-88. DOI: 10.12376/j.issn.2097-0501.2022.01.014

商业健康保险在中国罕见病医疗保障中的应用现状、问题及对策

Application Status, Problems and Suggestions of Commerical Health Insurance in Medical Security for Rare Dsieases in China

  • 摘要: 目前罕见病诊治与保障已成为社会关注的焦点。商业健康保险作为中国多层次医疗保障体系的重要组成部分,对基本医疗保险的补充作用日益显现,且近年来医保改革政策红利恰好为商业健康保险在罕见病保障领域的应用提供了广阔空间和重大机遇。本文将阐述罕见病患者医疗保障现状、罕见病纳入商业健康保险承保范围的必要性和现实可行性,并分析商业健康保险在罕见病保障的应用现状及存在问题,为充分发挥商业健康保险的积极作用,完善多层次罕见病保障体系,提出针对性的政策建议。

     

    Abstract: At present, the diagnosis, treatment, and social security of rare diseases have attracts social attention. As an important part of the multi-level health insurance system in China, commercial health insurance plays an increasingly important role in the supplement to basic medical insurance. Moreover, recently, the benefits of new healthcare reform policies have provided much room and great opportunities for the application of commercial health insurance for rare disease.This paper presents current medical insurance for patients with rare diseases and discuss the necessity and feasibility of bringing rare diseases into the coverage of commercial health insurance, and analyzes the current application and the potential problems of rare disease insurance in the commercial health insurance. This article also gives suggestions to the policies to make full use of the positive role of commercial insurance for the completion of multi-level health insurance system for rare disease.

     

/

返回文章
返回